Advancing Tumor-Targeted Chemo-Immunotherapy: Development of the CAR-M-derived Exosome-Drug Conjugate
Yunhan Jiang(Sichuan University), Tao Yang(Sichuan University), Xiaoqiu Xu(Sichuan University), Youfu Luo(Sichuan University), Yingqiang Guo(Sichuan University), Dongmei Fan(China Academy of Transportation Sciences), Mengdi Cheng(Northwest University), Jiasheng Huang(Sichuan University), Meng Zhou(Sichuan University), Pingxian Liu(Sichuan University)
Cited by 18
Related Papers
Forkhead box O proteins: steering the course of stem cell fate
|Cell Regeneration|2024|12
The U.S. FDA approved cardiovascular drugs from 2011 to 2023: A medicinal chemistry perspective
|European Journal of Medicinal Chemistry|2024|10
CAR-engineered cytolytic Tregs reverse pulmonary fibrosis and remodel the fibrotic niche with limited CRS
|JCI Insight|2025|9
Differences in the content of human milk oligosaccharides between foremilk and hind milk
|Food Bioengineering|2023|6
FoxO is required for neoblast differentiation during planarian regeneration
|International Journal of Biological Macromolecules|2024|5